Ibex Medical Analytics vs Sectra Pathology

Sectra supplies the slide viewer and Ibex supplies the algorithm. IDS7 handles case navigation, reporting and image review, and the Digital Pathology Module holds FDA 510(k) clearances from March 2020 and April 2024. A health system that wants pathology and radiology images in one viewer buys Sectra. A lab that already scans and wants an FDA-cleared prostate second read (K241232, January 2025) takes Ibex, whose breast and gastric tools remain research use only in the US. Sectra says more than 50 pathology AI vendors are integrated, and each algorithm bought through its marketplace carries its own vendor and regulatory status. The Sectra clearance covers the viewing module only, so a lab that needs a cleared prostate algorithm still needs a vendor like Ibex. Neither publishes a price.